Market Overview

Ascendiant Capital Markets Reiterates Strong Buy Rating, $3.75 PT on Solta Medical

Related SLTM
Benzinga's M&A Chatter for Monday December 16, 2013
Mid-Afternoon Market Update: Markets Rise as Twitter Pulls Back

In a report published Wednesday, Ascendiant Capital Markets reiterated its Strong Buy rating and $3.75 price target on Solta Medical (NASDAQ: SLTM).

Ascendiant Capital Markets noted, “Yesterday, Solta announced that it has entered into a definitive agreement to acquire privately-held Sound Surgical Technologies LLC. Sound Surgical markets a suite of products, which utilize ultrasound technology, that primarily target plastic surgeons who perform liposuction procedures. The lead product is the VASER Lipo device, which uses ultrasound to facilitate the removal of fat in a minimally invasive procedure that results in a faster recovery for the patient compared to traditional liposuction procedures. The VASERsmooth procedure uses the same device platform to address cellulite. The VASER Shape is a non-invasive body shaping product.”

Solta Medical closed on Tuesday at $2.62.

Latest Ratings for SLTM

DateFirmActionFromTo
Dec 2013Leerink SwannDowngradesOutperformMarket Perform
Dec 2013Cantor FitzgeraldDowngradesBuyHold
Dec 2013Raymond JamesDowngradesOutperformMarket Perform

View More Analyst Ratings for SLTM
View the Latest Analyst Ratings

Posted-In: Ascendiant Capital MarketsAnalyst Color Reiteration Analyst Ratings

 

Related Articles (SLTM)

Around the Web, We're Loving...

Get Benzinga's Newsletters